Evaluation of peroxisome proliferator-activated receptor agonists on interleukin-5-induced eosinophil differentiation

Peroxisome proliferator-activated receptor (PPAR) agonists have been suggested as novel therapeutics for the treatment of inflammatory lung disease, such as allergic asthma. Treatment with PPAR agonists has been shown to inhibit airway eosinophilia in murine models of allergic asthma, which can occu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Smith, Steven G, Hill, Mike, Oliveria, John-Paul, Watson, Brittany M, Baatjes, Adrian J, Dua, Benny, Howie, Karen, Campbell, Heather, Watson, Rick M, Sehmi, Roma, Gauvreau, Gail M
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Science Inc 2014
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4080964/
https://ncbi.nlm.nih.gov/pubmed/24628018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imm.12280
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados